Therapeutic inhibition of Mcl-1 blocks cell survival in estrogen receptor-positive breast cancers

od Williams, Michelle M., Elion, David L., Rahman, Bushra, Hicks, Donna J., Sanchez, Violeta, Cook, Rebecca S.
izdano v Oncotarget (2019)

Host-deficiency in Vav 2/3 guanine nucleotide exchange factors impairs tumor growth, survival, and angiogenesis in vivo

od Brantley-Sieders, Dana M., Zhuang, Guanglei, Vaught, David, Freeman, Tanner, Hwang, Yoonha, Hicks, Donna, Chen, Jin
Izdano 2009

Staphylococcus xylosus Cystitis and Struvite Urolithiasis in Nude Mice Implanted with Sustained-release Estrogen Pellets

od Salleng, Kenneth J, Jones, Carissa P, Boyd, Kelli L, Hicks, Donna J, Williams, Michelle M, Cook, Rebecca S
izdano v Comp Med (2018)

Optical metabolic imaging identifies glycolytic levels, sub-types and early treatment response in breast cancer

od Walsh, Alex J., Cook, Rebecca S., Manning, H. Charles, Hicks, Donna J., Lafontant, Alec, Arteaga, Carlos L., Skala, Melissa C.
Izdano 2013

mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis

od Morrison, Meghan M., Young, Christian D., Wang, Shan, Sobolik, Tammy, Sanchez, Violeta M., Hicks, Donna J., Cook, Rebecca S., Brantley-Sieders, Dana M.
izdano v PLoS Genet (2015)

Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth

od Morrison, Meghan M., Williams, Michelle M., Vaught, David B., Hicks, Donna, Lim, Jiyeon, McKernan, Courtney, Aurisicchio, Luigi, Cennaro, Gilberto, Simion, Catalina, Sweeney, Colleen, Cook, Rebecca S.
izdano v Oncogene (2015)

ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation

od Williams, Michelle M., Vaught, David B., Joly, Meghan Morrison, Hicks, Donna J., Sanchez, Violeta, Owens, Philip, Rahman, Bushra, Elion, David L., Balko, Justin M., Cook, Rebecca S.
izdano v Breast Cancer Res (2017)

HER3 Is Required for HER2-Induced Preneoplastic Changes to the Breast Epithelium and Tumor Formation

od Vaught, David B., Stanford, Jamie C., Young, Christian, Hicks, Donna J., Wheeler, Frank, Rinehart, Cammie, Sánchez, Violeta, Koland, John, Muller, William J., Arteaga, Carlos L., Cook, Rebecca S.
Izdano 2012

Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis

od Morrison Joly, Meghan, Williams, Michelle M., Hicks, Donna J., Jones, Bayley, Sanchez, Violeta, Young, Christian D., Sarbassov, Dos D., Muller, William J., Brantley-Sieders, Dana, Cook, Rebecca S.
izdano v Breast Cancer Res (2017)

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling

od Brantley-Sieders, Dana M., Zhuang, Guanglei, Hicks, Donna, Fang, Wei Bin, Hwang, Yoonha, Cates, Justin M.M., Coffman, Karen, Jackson, Dowdy, Bruckheimer, Elizabeth, Muraoka-Cook, Rebecca S., Chen, Jin
Izdano 2007

Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade

od Williams, Michelle M., Lee, Linus, Hicks, Donna J., Joly, Meghan M., Elion, David, Rahman, Bushra, McKernan, Courtney, Sanchez, Violeta, Balko, Justin M., Stricker, Thomas, Estrada, Monica Valeria, Cook, Rebecca S.
izdano v Mol Cancer Res (2016)

Rictor/mTORC2 drives progression and therapeutic resistance of HER2-amplified breast cancers

od Joly, Meghan Morrison, Hicks, Donna J., Jones, Bayley, Sanchez, Violeta, Estrada, Monica Valeria, Young, Christian, Williams, Michelle, Rexer, Brent N., Sarbassov, Dos D., Muller, William J., Brantley-Sieders, Dana, Cook, Rebecca S.
izdano v Cancer Res (2016)

Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers

od Williams, Michelle M., Lee, Linus, Werfel, Thomas, Joly, Meghan M. Morrison, Hicks, Donna J., Rahman, Bushra, Elion, David, McKernan, Courtney, Sanchez, Violeta, Estrada, Monica V., Massarweh, Suleiman, Elledge, Richard, Duvall, Craig, Cook, Rebecca S.
izdano v Cell Death Dis (2018)

Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution

od Stanford, Jamie C., Young, Christian, Hicks, Donna, Owens, Philip, Williams, Andrew, Vaught, David B., Morrison, Meghan M., Lim, Jiyeon, Williams, Michelle, Brantley-Sieders, Dana M., Balko, Justin M., Tonetti, Debra, Earp, H. Shelton, Cook, Rebecca S.
izdano v J Clin Invest (2014)

ErbB3 downregulation enhances luminal breast tumor response to antiestrogens

od Morrison, Meghan M., Hutchinson, Katherine, Williams, Michelle M., Stanford, Jamie C., Balko, Justin M., Young, Christian, Kuba, Maria G., Sánchez, Violeta, Williams, Andrew J., Hicks, Donna J., Arteaga, Carlos L., Prat, Aleix, Perou, Charles M., Earp, H. Shelton, Massarweh, Suleiman, Cook, Rebecca S.
Izdano 2013

Selective mTORC2 inhibitor therapeutically blocks breast cancer cell growth and survival

od Werfel, Thomas A., Wang, Shan, Jackson, Meredith A., Kavanaugh, Taylor E., Joly, Meghan Morrison, Lee, Linus H., Hicks, Donna J., Sanchez, Violeta, Ericsson, Paula Gonzalez, Kilchrist, Kameron V., Dimobi, Somtochukwu C., Sarett, Samantha M., Brantley-Sieders, Dana, Cook, Rebecca S., Duvall, Craig L.
izdano v Cancer Res (2018)

Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials

od Lovly, Christine M., Dahlman, Kimberly Brown, Fohn, Laurel E., Su, Zengliu, Dias-Santagata, Dora, Hicks, Donna J., Hucks, Donald, Berry, Elizabeth, Terry, Charles, Duke, MarKeesa, Su, Yingjun, Sobolik-Delmaire, Tammy, Richmond, Ann, Kelley, Mark C., Vnencak-Jones, Cindy L., Iafrate, A. John, Sosman, Jeffrey, Pao, William
Izdano 2012

BRAF L597 mutations in melanoma are associated with sensitivity to MEK inhibitors

od Dahlman, Kimberly Brown, Xia, Junfeng, Hutchinson, Katherine, Ng, Charles, Hucks, Donald, Jia, Peilin, Atefi, Mohammad, Su, Zengliu, Branch, Suzanne, Lyle, Pamela L., Hicks, Donna J., Bozon, Viviana, Glaspy, John A., Rosen, Neal, Solit, David B., Netterville, James L., Vnencak-Jones, Cindy L., Sosman, Jeffrey A., Ribas, Antoni, Zhao, Zhongming, Pao, William
Izdano 2012

Triple negative breast cancers with amplification of JAK2 at the 9p24 loci demonstrate JAK2-specific dependence

od Balko, Justin M., Schwarz, Luis J., Cook, Rebecca S., Estrada, Monica V., Giltnane, Jennifer M., Sanders, Melinda E., Sánchez, Violeta, Dean, Phillip T., Wang, Kai, Combs, Susan E., Hicks, Donna, Pinto, Joseph A., Landis, Melissa D., Chang, Jenny C., Doimi, Franco D., Gómez, Henry, Rimm, David L., Yelensky, Roman, Miller, Vincent A., Stephens, Phillip J., Arteaga, Carlos L.
izdano v Sci Transl Med (2016)